Latest Articles in ICU

ICU Management & Practice 2021 Author Index

Aarab Y  20   https://iii.hm/17j3 ,  162   https://iii.hm/1agk Allen J  52   https://iii.hm/17jm Artigas A  70   https://iii.hm/18so ,  174  https://iii.hm/1bk3 ,  176   https://iii.hm/1bk5 Banner-

Read more

Clinical Haematology

P atients in the intensive care unit frequently report haematological issues. These issues are often a result of critical illness. The most common haematological complications seen in the ICU include thrombocytopenia, anaemia, leukocytosis, thrombocytosis, and coagulopathies. In addition, emergen

Read more

Reversal of Direct Oral Anticoagulants

This review focuses on different techniques to reverse direct oral anticoagulants,  either with specific or non-specific agents. D irect oral anticoagulants (DOACs) are now standing for Vitamin K antagonists in many clinical settings. They are recognised as a major step fo

Read more

Anaemia in the Critically Ill: What is the Major Culprit?

Anaemia is commonly encountered in the critically ill and is associated with poor outcomes. The cause is multifactorial and includes high hepcidin levels and a blunted response to erythropoietin. A naemia is defined by haemoglobin (Hb) < 12 g/dL for women and Hb below 13 g/dL for m

Read more

Management of Pulmonary Embolism in the Intensive Care Unit

Pulmonary embolism is a reason for admission to the Intensive Care Unit and this complication in hospitalised patients is associated with high morbidity and mortality. The identification and management of pulmonary embolism is a challenge for doctors. Introduction Pulmonary Embolism

Read more

Emergencies in Malignant Haematology for the Intensivist

An overview of emergencies that are commonly seen in malignant haematology, side effects of novel therapies, and complications of allogeneic haematologic stem cell transplant. Introduction Critical illness is common in patients with haematologic malignancies. Recent data demons

Read more

CAR-T Cell Therapy – What An Intensivist Should Know

CAR-T therapy is a promising treatment for B-cell malignancies but is also associated with toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). Frequent monitoring, timely recognition and prompt management in ICU are paramount to

Read more

Nutritional Care for Patients with COVID-19 Requiring Intensive Care

Recommendations for the management of nutrition of COVID-19 patients provide guidelines for nutrition risk screening, requirements, timing, route and mode of feeding, monitoring, equipment and workforce requirements. The worldwide pandemic of COVID-19 continues to impact all aspects of inten

Read more

The Importance of Accurate Glucose Monitoring in Critically Ill Patients

The complexity of glucose testing, the limitations of point-of-care blood glucose monitoring systems and the need for accuracy and reliability to ensure optimised patient outcomes. C ritically ill patients are not found just in intensive care units, but throughout the hospital

Read more

Clinical Haematology Digital Conference

Join our panellists on November 30 at 16:00 CET as they discuss coagulation, anaemia, haematological malignancy, and other important presentations of haematological disease in critical care. Register here ! Moderator Jean-Louis Vincent  Editor-in-Chief ICU Management &amp

Read more

Highlighted Products